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Abstract 
Background:To observe the effects of Ferrous 
sulphate on the body of gastric mucosa of adult 
albino rats. 
Methods: An experimental study was carried out 
on 30 adult albino Wistar rats for 12 weeks.Two 
groups were made; A and B. They were divided 
further into A1, A2, B1 and B2 for qualitative 
parameters and statistical purposes.Group A was 
kept as control and divided into 2 sub groups; A1 
and A2 and was given normal food and water. The 
experimental group B was divided into 2 sub groups 
B1 and B2. Ferrous sulphate was given orally for 4 
and 12 weeks respectively through gavage needle for 
maximum efficacy in the experimental group.Albino 
rat’s stomach was dissected, fixed in 10% formalin 
and processed for light microscopy. The short and 
long term effects of ferrous sulphate were observed 
on 4th and 12th week respectively. For histological 
analysis H&E was used. Body of gastric mucosa of 
adult albino rat was considered for this study.  
Results: Change in the colour of mucosa was found 
in 10 (100%) of cases at 12 weeks whereas only 8 
(80%) cases showed changes after 4 weeks. 
Haemorrhage was seen scattered in 4 (40%) cases 
after 4 weeks whereas present in all 10 (100%) cases 
after 12 weeks. Ulcer was seen in 4 (40%) of cases 
after 12 weeks. Epithelial changes were seen in 5 
(50%) cases at 4 and 8 (80%) of cases after 4 and 12 
weeks respectively. Ulcerative changes were seen in 
4 (40%), granulation tissue/ fibrosis was seen in 7 
(70%) cases in experimental group only. There was a 
significant decrease in the weight of rats from 226.69 
±22.31mg to 169.43±22.39mg in the experimental 
group with p ˂.001. Inflammatory cell count 
significantly increased from (4.03± 1.02) to 17.01±5.01 
in the experimental group with p˂.001.  
Conclusion: Ferrous Sulphate  has detrimental 
effects on the gastric mucosa of adult albino rats. 
Haemorrhages, ulcerated areas and change in colour 
of mucosa was observed with naked eye. 
Inflammatory cell infiltrate was found to be the most 
common presentation.  
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Introduction 
Iron deficiency anaemia is a common nutritional 
deficiency caused by either decreased use or increased 
loss of Iron. Iron sulphate (FeSO4) is the  most 
commonly administered drug to overcome iron 
deficiency anaemia in pregnancy and post partum 
period and is an important constituent of nutrition for 
growth of children and adultsIron is an important 
metal and is considered to be an integral part of many 
proteins as haemoglobin and myoglobin. It also plays 
an important role in DNA synthesis1-3 In 19th century, 
oral iron therapy has been the most commonly used 
therapy for iron deficiency anaemia4. Anaemia is the 
commonest cause of malnutrition affecting 43% of 
children worldwide as stated by WHO.5 More adverse 
effects were seen in patients getting simple ferrous 
sulphate than with extended release tablets.6 Iron 
deficiency anaemia has found to be the foremost 
nutritional deficiency in Pakistan. The prevalence of 
anaemia in Pakistan is 83%, 78%, 85% and 82.9% 
among pregnant, lactating women, adolescent girls 
and children respectively.7 
The importance of iron is also emphasized in Surah 
Hadith of Holy Quran where it is stated “And we also 
sent down iron in which lies great dangers and it has 
many uses for mankind”.8 Iron is present in ferrous 
(Fe2+) and ferric (Fe3+) states.4,9 Ferrous salts are 3 
times more absorbed than ferric salts.4 FeSO4 tablet is 
the most commonly used oral form of iron (325mg 
tablet contains 65mg iron).10,11,13 Other iron 
preparations are Ferrous Fumarate and Ferrous 
Gluconate.12 Less commonly used are iron amino 
chelate and iron polymaltose.3 Injectable forms are 
Iron sucrose, Iron dextran, Sodium Ferric Gluconate 
and Ferrumoxytol but experienced staff is required for 
intravenous use as there is risk of allergic reactions.14,15 
Oral iron tablets are easy to use, cheap, and easily 
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available hence no hospital staff or methods are 
required for their use.16 
 FeSO4 is an important constituent of our nutrition yet 
it creates reactive oxygen species also known as free 
radicals.17,19,20 They are harmful for the body causing 
wide range of tissue and organ damage.19, 20 Injury has 
been observed in a few cases in gastrointestinal tract 
due to the usage of oral iron tablets.21 Oral iron 
mucosal injury has a prevalence of 0.7% and may be 
seen at only 5 days after the iron treatment has been 
initiated in humans.5 
The difference between anatomy of human stomach 
and rat stomach is that human stomach has proper 
fundus, body and antrum with glandular simple 
columnar epithelium whereas in rat stomach, most of 
the stomach is covered by non glandular stratified 
squamous epithelium and a small lower part is 
composed of simple columnar epithelium. This leaves 
a small fundus, proper body and a very small 
antrum.18 
 
Material and Methods 
The experimental study was carried out in the animal 
house of Anatomy Department, Post Graduate 
Medical Institute, Lahore. Thirty albino rats 55-60 days 
old of either sex weighing (150-250gms) were 
procured from NIH, Islamabad after Ethical 
Committee approval. Two groups were made and 
each was further divided into 2 subgroups.  One was 
control and other experimental group which was given 
FeSO4 at therapeutic dosage. The duration of study 
was one year and the experiment was conducted for 12 
weeks. They were housed separately in climate 
controlled environment and were kept on normal feed 
and water. All rats used in the study were handled 
with international, natural and institutional guidelines 
for care and use of laboratory animals as promulgated 
by the Canadian Council of Animal Care (1984). They 
were housed in cages with bar lids used to hold water 
bottles and feed to prevent contamination with urine 
or faeces. They were kept in ventilated room at 
ambient temperature of 28±2.0º C and humidity 
(60±10%) under 12 hour light /dark cycles and water 
ad libitum. Each rat was tagged randomly on the tail. 
Following acclimatization of one week, each rat was 
weighed at the commencement of the study and on 4th 
and 12th week respectively. Ferrous   sulphate was 
obtained in the crystalline form and dose was given by 
dissolving ferrous sulphate in water. Dose was 
calculated to be 27mg/kg/day. 
The dose was given through gavage needle to make 
sure that the drug had efficiently and completely 
reached the gastric mucosa. To make a model 
comparable to humans as there is little compliance to 
multivitamins, iron sulphate was given once a day in 
morning with empty stomach to observe the maximal 
effect. After 4th and 12th week, respective rats were put 
in chloroform chamber and cervical dislocation was 
done under deep anesthesia. The surgical procedure 
was carried out under sterile conditions. The 
anesthetized animal was placed with limbs stretched 
on the operating board. A midline incision was given 
from the centre of neck extending downwards till the 
end with a scalpel and knife. The two flaps were 
divided in two parts by giving horizontal incision in 
the skin of both sides. Stomach was identified behind 
the liver and was opened along the greater curvature. 
It was washed with normal saline to remove food 
debris and secretions. The gastric mucosa was 
stretched out with the help of forceps.  Naked eye 
examination was done to see change in colour, 
hemorrhage and ulcer. The histological analysis of the 
mucosa was done through light microscope. The 
stomach was photographed before taking sections. 
Sections were taken randomly from the body of the 
gastric mucosa and placed in cassette with labels and 
fixed in neutral 10% buffered formalin for 48 hours. 
Tissue processing was done and blocks were kept in 
refrigerator. They were mounted on rotary microtome 
and 5µm consecutive thick sections were lifted on it. 
Slides were labeled with a lab code and number was 
given accordingly. 
Haemotoxylin and Eosin stain was used to see the 
histological changes in the mucosa. Quantitative 
parameters were assessed by eye piece micrometer 
scale which was calibrated against the stage 
micrometer. Quantitative variables were given as 
mean ± standard deviation and categorical data was 
shown as frequencies and percentages.   
 
Results 
On gross examination no significant change in colour 
of gastric mucosa in control groups A1 and B1 was 
observed. There was significant change in group A2 at 
4 weeks (p˂ .007) and group B2 after 12 weeks (p˂ 
.001) was observed. The mucosa appeared  dull, 
congested, oedematous and reddish (Table 1).In group 
A1and B1, haemorrhage could not be visualized. In 
group A2 hemorrhagic areas were seen in 4 (40%) 
cases after 4 weeks (p˂.231) and 10 (100%) cases after 
12 weeks of ferrous sulphate dosage (p ˂ .001). Ulcer 
could not be visualized in any of cases in groups A1, 
A2 and B1. In group B2, 4 (40%) cases showed 
ulceration after 12 weeks (Table 1; Figure 1). In 
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qualitative parameters ulcers were seen in 4 (40%) 
cases in group B2 only (Table 2;Figure 2 ). 
Table 1: Comparison of gross qualitative 
parameters after 4 and 12 weeks on body of 
gastric mucosa 
Qualitative 
Parameters 
Contro
l 
Gp.A1 
Exp 
Gp.B
1 
P-
Value 
Contr- 
ol 
Gp.A2 
Exp 
Gp.B
2 
p-
Val-
ue 
B1Vs 
B2 
p.va-
lue 
Change in 
Color of 
Mucosa 
0(0%) 8 
(80%
) 
.007*
* 
0 
(0%) 
10 
(100
%) 
<.0
01*
** 
.474 
Presence of 
lesion 
(erosion) 
0(0%) 0(0%
) 
NA 0(0%) 5(50
%) 
.10
1 
.033* 
Hemorrhage 0(0%) 4 
(40%
) 
.231 0(0%) 10 
(100
%) 
<.0
01*
** 
.011 
Ulcer 0(0%) 0(0%
) 
NA 0(0%) 4(40
%) 
.23 .087 
 *p˂.05,**P˂.01, ***P˂.001, Fischer exact test used for 
comparison;N=number of rats: A1 (n=5); A2 (n=5);B1 (n=10); B2 
(n=10) 
Table 2: Comparison of histological qualitative 
parameters after 4 and 12 weeks on  body of 
gastric mucosa 
 
 *p˂.05, **p˂.01, Fischer exact test used for comparison 
 
Fig 1. Body of gastric mucosa (group B1) showing congested and 
hemorrhagic vessels (red arrow) and neutrophils (black arrow) 
with mast cells (blue arrows) after 4 weeks of experiment 
 
Granulation tissue and fibrosis was seen in 7 (70%) 
cases in group B (Figure 2).In quantitative parameters 
there was a significant increase in weight of the rats  in 
control group; 185.39±18.02 (mg) than experimental 
group; 199.99±16.33 (mg) at 4 weeks (group B1) and 
226.69±22.31 (mg) after 12 weeks (group B2) (table 3). 
In  group B1, there was a slight increase in the  weight 
of the rats from 174.61±16.33 (mg) to 183.14±22.79 
(mg) after 4 weeks of ferrous sulphate usage. In group 
B2, the weight of the rats significantly decreased from 
177.19±18.62 (mg) to 169.43±22.39 (mg) after 12 
weeks.There was significant increase in inflammatory 
cell count from 4.03±1.02 (µm) to 11.15±3.28 (µm) after 
4 weeks of experiment (p˂ .001) and increased 
significantly to 17.01±5.01 (µm) after 12 weeks (p˂ 
.001) (Table. 4 ; Figure 3). 
 
Fig 2. Body of gastric mucosa (group B2) showing erosion 
and ulcerative changes(black arrow), congested and 
hemorrhagic vessels(red arrow) and inflammatory cell 
infiltrate (blue arrow) after 12 weeks of ferrous sulphate 
ingestion. 
Table 3: Comparison of groups showing 
significant change in weights after 4 and 12 
weeks on body of gastric mucosa      
 
                   ***p˂.001 
Table 4: Comparison of  groups showing 
significant change in inflammatory cell count 
after 4 and 12 weeks in body of gastric mucosa 
Quantitative 
Parameters 
Control Exp Gp. 
B1 
Exp Gp. 
B2 
ANOVA 
  Mean± SD Mean± SD Mean± SD F p 
Inflammatory 
Cell Count 4.03±1.02 
11.15±3.2
8 
17.01±5.0
1 
33.8
8 
<.001
* 
*p˂.0001 
.
0
2
4
6
8
10
12
14
16
18
Control Exp Gp. B1 Exp Gp. B2
M
ea
n
Inflammatory Cell Count 
Inflammatory Cell Count
 
Figure 3:Escalation in inflammatory cell count in body of 
gastric mucosa of albino rats at 4 and 12 week. 
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Discussion 
Most of the previous light microscopic studies on 
ferrous sulphate focused on intestinal mucosa.3,19  
Little attention has been directed at changes occurring 
in the gastric mucosa. However, some studies showed 
the detrimental effect of FeSO4 on the gastric mucosa 
but the information is very scarce and limited.1,2,22,23 
Due to ethical considerations, adult albino Wistar rats 
were taken for experiment. The similarities in the 
gastric mucosa of rats are more than the differences 
from the human gastric mucosa so the results 
concluded can be considered for humans.30 In the 
present study, the most important feature was 
increased inflammatory count. This finding was in 
accord with the one reported earlier by  Toblli et al; 
2008 and Kumar et al; 2013 after use of FeSO4 in the 
gastrointestinal mucosa of adult albino rats that 
inflammatory cell count is increased in body of gastric 
mucosa after utilizing FeSO4.3, 6 Chronic inflammation 
after use of iron medication was documented earlier 
by  Hiraishi et al; 1991 augmenting the current study 
22. Increased inflammation was also observed by Kaye 
et al; 2008 similar to the current study.23 Erosions, 
haemorrhages and ulcers were visualized on gross and 
histological study by Ji and Yardley, 2004 and Cimino-
Mathews et al; 2010. These findings potentiated the 
current study.24,25 Ulcers were also observed by 
Marginean et al; 2006 and Hashash et al; 2013 which 
were similar to the present study.27,28 It was 
documented by Laine et al; 1998 and Marginean et al; 
2006 that ulcers were produced in the gastric mucosa 
of albino rats.26,27 It was proved by Reagen- Shaw et al; 
2007 that a few ulcerated or necrotic areas were seen 
along with deposits of iron in the gastric mucosa29. It 
was observed by Toblli et al; 2008 that there was a 
significant change in the weight of rats receiving 
FeSO4. This owed to the disturbed bowel movements 
caused by the drug. This study potentiated the current 
study where rats lost weight after 12 weeks of iron 
sulphate ingestion.30 Formation of fibrous bands and 
granulation tissue was also evaluated by Zhang et al; 
2008 in a study which also potentiated the current 
study.20 
Conclusion 
Extensive use of ferrous sulphate used in common 
clinical practice can cause injury and harm to the 
gastric mucosa. 
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